Email the author Hydrophilic/hydrophobic wound care preparation based on the nanoscale silica: physicochemical and technological aspects
DOI: https://doi.org/10.15407/hftp13.02.160
Abstract
Неaling of infected ulcers and wounds, particularly in older people, is a serious problem in modern surgery. As a result of many years efforts, we have created an innovative wound care composition that has high absorptive, anti-inflammatory and wound-healing capabilities and are starting the clinical study of it. The composition, which got a trade mark Pathelen®, contains nanoscale hydrophilic silica (A-300), hydrophobic silica (Aerosil® R972 Pharma) and benzalkonium chloride. This work aimed to develop an optimal pathway of industrial production, as well as methods of quality control of the drug.
The examination of manufacture intermediates and the final product includes bulk density measurement, thermal analysis, IR spectroscopy, chemical methods of identification, adsorption capacity and microbial contamination control.
The pathway of manufacture which consists of mechanochemical immobilization of benzalkonium chloride on hydrophobic silica surface and mixing of obtained semi-product with hydrophilic nanoscale silica is developed. Thus, a technological method is proposed for combining hydrophilic and hydrophobic nanomaterials in one preparation. The final product complies to the elaborated quality parameters. In particular, the bulk density is distributed in a range 50–60 g/L, the adsorption capacity is not less than 140 mg of protein per gram. The absence of pathogenic microorganisms and fungi was demonstrated; the quantity of non-pathogenic microorganisms meets the requirements of the European Pharmacopoeia for products in this category.
The results obtained can be useful for the organization a large-scale production of the proposed drug in future.
Keywords
Full Text:
References
1. Boulton A.J., Vileikyte L., Ragnarson-Tennvall G., Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005. 366(9498): 1719. https://doi.org/10.1016/S0140-6736(05)67698-2
2. International Working group on the Diabetic Foot (IWGDF). The development of global consensus guidelines on the management and prevention of the Diabetic Foot. 2015. http:// www.iwgdf.org
3. Huang S.S., Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin. Infect. Dis. 2003. 36(3): 281. https://doi.org/10.1086/345955
4. Kaye K.S., Anderson D.J., Choi Y., Link K., Thacker P., Sexton D.J. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin. Infect. Dis. 2008. 46(10): 1568. https://doi.org/10.1086/587673
5. Cooney D.O. Activated charcoal in medical applications. In: Informa healthcare. 2nd ed. (New York-London: CRC Press, 1995). https://doi.org/10.1201/9780367803964
6. Giordano C. Sorbents and their clinical applications. (New York-London: Academic Press, 1980).
7. Furr J.R., Russell A.D., Turner T.D., Andrews A. Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. J. Hosp. Infect. 1994. 27(3): 201. https://doi.org/10.1016/0195-6701(94)90128-7
8. Bradley M., Cullum N., Nelson E.A., Petticrew M., Sheldon T., Torgerson D. Systematic reviews of wound care management: (2) dressings and topical agents used in the healing of chronic wounds. Health Technol. Assess. 1999. 3(17 Pt 2): 1. https://doi.org/10.3310/hta3172
9. Skorkowska-Telichowska K., Czemplik M., Kulma A., Szopa J. The local treatment and available dressings designed for chronic wounds. J. Am. Acad. Dermatol. 2013. 68(4): 117. https://doi.org/10.1016/j.jaad.2011.06.028
10. Blitz J.P., Gun'ko V.M. Surface chemistry in biomedical and environmental science. (Dordrecht, the Netherlands: Springer, 2006). https://doi.org/10.1007/1-4020-4741-X
11. Znamenskiy V.A., Vozianov A.F., Vozianova Zh.M., Keisevych L.V., Zhyla V.V., Gebesh V.V., Kaban A.M., Kozinetc G.P., Kostrub A.A., Belyaeva O.A., Savich E.I., Dyachenko E.I., Sukhanova A.A., Alexeenko E.P., Shevchenko Yu.N., Samodumova I.M., Kiseleva L.I., Prikhod'ko L.N. The use of therapeutic and prophylactic preparations produced on the basis of silicon-organic sorbents. Regulatory Document of Ministry of Health of Ukraine. 1994.
12. Baksa J. Selection of wound dressings. Orv. Hetil. 2000. 141(47): 2549.
13. Vil'tzanyuk A.A., Gerashchenko I.I., Cheplyaka A.N. Experimental and clinical substantiation in application of hydrophilic-hydrophobic silica-containing compositions for local treatment of pus injuries. Kharkiv Surg. Sch. 2008. 28(1): 53. [in Russian].
14. European Pharmacopoeia. 8th ed. (Strasborgh: EDQM, 2013).
15. Voronin E.F., Nosach L.V., Guzenko N.V., Pakhlov E.M., Gabchak O.L. Adsorption modification of nanosilica with non-volatile organic compounds in fluidized state. In: Nanomaterials and Supramolecular Structures: Physics, Chemistry and Applications. (London: Springer, 2009). https://doi.org/10.1007/978-90-481-2309-4_13
16. Eur. Patent PCT/EP2019/052021. Gerashchenko I., Chepliaka O. Hydrophilic/hydrophobic pharmaceutical composition and method of its production and use. 2019.
17. Patent US 10,226,425 B2. Gerashchenko I., Chepliaka O. Pharmaceutical preparation and method of its production and use. 2019.
DOI: https://doi.org/10.15407/hftp13.02.160
Copyright (©) 2022 I. I. Gerashchenko, K. O. Stepanyuk, O. M. Chepliaka, M. V. Borysenko, E. M. Pakhlov, D. G. Klyuchkov, K. G. Vinogradova
This work is licensed under a Creative Commons Attribution 4.0 International License.